These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17694590)

  • 1. Design and synthesis of cyclopeptide analogues of the potent histone deacetylase inhibitor FR235222.
    Gomez-Paloma L; Bruno I; Cini E; Khochbin S; Rodriquez M; Taddei M; Terracciano S; Sadoul K
    ChemMedChem; 2007 Oct; 2(10):1511-9. PubMed ID: 17694590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis of cyclic tetrapeptide FR235222, a potent immunosuppressant that inhibits mammalian histone deacetylases.
    Xie W; Zou B; Pei D; Ma D
    Org Lett; 2005 Jun; 7(13):2775-7. PubMed ID: 15957944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis, NMR solution structure, and binding model of the potent histone deacetylase inhibitor FR235222.
    Rodriquez M; Terracciano S; Cini E; Settembrini G; Bruno I; Bifulco G; Taddei M; Gomez-Paloma L
    Angew Chem Int Ed Engl; 2006 Jan; 45(3):423-7. PubMed ID: 16311994
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222.
    Di Micco S; Terracciano S; Bruno I; Rodriquez M; Riccio R; Taddei M; Bifulco G
    Bioorg Med Chem; 2008 Sep; 16(18):8635-42. PubMed ID: 18715788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases.
    Bhuiyan MP; Kato T; Okauchi T; Nishino N; Maeda S; Nishino TG; Yoshida M
    Bioorg Med Chem; 2006 May; 14(10):3438-46. PubMed ID: 16439135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework.
    Shivashimpi GM; Amagai S; Kato T; Nishino N; Maeda S; Nishino TG; Yoshida M
    Bioorg Med Chem; 2007 Dec; 15(24):7830-9. PubMed ID: 17881232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222.
    Terracciano S; Di Micco S; Bifulco G; Gallinari P; Riccio R; Bruno I
    Bioorg Med Chem; 2010 May; 18(9):3252-60. PubMed ID: 20381359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides.
    Nishino N; Shivashimpi GM; Soni PB; Bhuiyan MP; Kato T; Maeda S; Nishino TG; Yoshida M
    Bioorg Med Chem; 2008 Jan; 16(1):437-45. PubMed ID: 17900911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors.
    Angibaud P; Arts J; Van Emelen K; Poncelet V; Pilatte I; Roux B; Van Brandt S; Verdonck M; De Winter H; Ten Holte P; Marien A; Floren W; Janssens B; Van Dun J; Aerts A; Van Gompel J; Gaurrand S; Queguiner L; Argoullon JM; Van Hijfte L; Freyne E; Janicot M
    Eur J Med Chem; 2005 Jun; 40(6):597-606. PubMed ID: 15922843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2-amino-8-oxodecanoic acids (Aodas) present in natural hystone deacetylase inhibitors.
    Rodriquez M; Bruno I; Cini E; Marchetti M; Taddei M; Gomez-Paloma L
    J Org Chem; 2006 Jan; 71(1):103-7. PubMed ID: 16388624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand.
    Nishino N; Yoshikawa D; Watanabe LA; Kato T; Jose B; Komatsu Y; Sumida Y; Yoshida M
    Bioorg Med Chem Lett; 2004 May; 14(10):2427-31. PubMed ID: 15109626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydocin-hydroxamic acid analogues as histone deacetylase inhibitors.
    Nishino N; Jose B; Shinta R; Kato T; Komatsu Y; Yoshida M
    Bioorg Med Chem; 2004 Nov; 12(22):5777-84. PubMed ID: 15498654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor.
    Yurek-George A; Cecil AR; Mo AH; Wen S; Rogers H; Habens F; Maeda S; Yoshida M; Packham G; Ganesan A
    J Med Chem; 2007 Nov; 50(23):5720-6. PubMed ID: 17958342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of a potent histone deacetylase inhibitor.
    Liu T; Kapustin G; Etzkorn FA
    J Med Chem; 2007 May; 50(9):2003-6. PubMed ID: 17419603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of histone deacetylase inhibitors that are based on FR235222: a cyclic tetrapeptide scaffold.
    Singh EK; Ravula S; Pan CM; Pan PS; Vasko RC; Lapera SA; Weerasinghe SV; Pflum MK; McAlpine SR
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2549-54. PubMed ID: 18381239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of azumamide A and azumamide E, evaluation as histone deacetylase inhibitors, and design of a more potent analogue.
    Wen S; Carey KL; Nakao Y; Fusetani N; Packham G; Ganesan A
    Org Lett; 2007 Mar; 9(6):1105-8. PubMed ID: 17311393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC). I. Taxonomy, fermentation, isolation and biological activities.
    Mori H; Urano Y; Abe F; Furukawa S; Furukawa S; Tsurumi Y; Sakamoto K; Hashimoto M; Takase S; Hino M; Fujii T
    J Antibiot (Tokyo); 2003 Feb; 56(2):72-9. PubMed ID: 12715864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward an HDAC6 inhibitor: synthesis and conformational analysis of cyclic hexapeptide hydroxamic acid designed from alpha-tubulin sequence.
    Jose B; Okamura S; Kato T; Nishino N; Sumida Y; Yoshida M
    Bioorg Med Chem; 2004 Mar; 12(6):1351-6. PubMed ID: 15018907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin.
    Furumai R; Komatsu Y; Nishino N; Khochbin S; Yoshida M; Horinouchi S
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):87-92. PubMed ID: 11134513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
    Bora-Tatar G; Dayangaç-Erden D; Demir AS; Dalkara S; Yelekçi K; Erdem-Yurter H
    Bioorg Med Chem; 2009 Jul; 17(14):5219-28. PubMed ID: 19520580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.